Skip to content
Monday 17 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,741.47
-0.08%
DAX
26,418.65
-0.08%
CAC 40
8,603.32
-0.39%
STOXX 50
6,546.83
+0.11%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 23 December 2025 2:02 pm

LivaNova to Present at J.P. Morgan Healthcare Conference in January

By: Business Wire

Add as a preferred source on Google

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria, Chief Executive Officer of LivaNova, and Alex Shvartsburg, Chief Financial Officer, will participate in a fireside chat on Wed., Jan. 14, 2026, at 1:30 p.m. Pacific Standard Time.

The discussion will be available to all interested parties who register to attend the webcast, which is accessible via www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup of the webcast. A replay will be available on the LivaNova website within 24 hours after the live presentation.

About LivaNova

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a vision to change the trajectory of lives for a new day. Through ingenious medical solutions in select neurological and cardiac conditions, LivaNova strives to ignite patient turnarounds. Headquartered in London, with approximately 3,000 employees and a presence in more than 100 countries, LivaNova serves patients, healthcare professionals, and healthcare systems worldwide. For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.

LivaNova CEO Vladimir Makatsaria and CFO Alex Shvartsburg at J.P. Morgan Healthcare Conference 2026 fireside chat

View source version on businesswire.com: https://www.businesswire.com/news/home/20251223148352/en/

Contact

LivaNova Investor Relations and Media Contacts

+1 281-895-2382
Briana Gotlin
VP, Investor Relations
[email protected]
Deanna Wilke
VP, Corporate Communications
[email protected]

Company Logo
Company Logo
Read more

Luxfer Announces Date of Second Quarter 2026 Earnings Conference Call

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Businesswire

Categories

  • Conference
  • Webcast

Trending Articles

  • Is the Zeekr 9X Super Hybrid the new luxury SUV to beat?

  • Grandparents fund university degrees to avoid inheritance tax net

  • US bond market jitters spark UK economy recession warning

  • FTSE 100 Live: Stocks rise as Trump threatens to declare Strait of Hormuz as US territory

  • Aldi boss wades into supermarket ‘price-gouging’ row

More from Morning Wire

  • Luxfer Announces Date of Second Quarter 2026 Earnings Conference Call

    Business Wire
  • Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

    Business Wire
  • Alkermes to Report Second Quarter Financial Results on July 28, 2026

    Business Wire
  • Alkermes plc Reports Second Quarter 2026 Financial Results

    Business Wire
  • Smurfit Westrock to Announce 2026 Second Quarter Results on July 29, 2026

    Business Wire
  • Arm Holdings plc Reports Results for the First Quarter of the Fiscal Year Ending 2027

    Business Wire
  • Arm Announces Earnings Release Date for First Quarter Fiscal Year Ended 2027

    Business Wire
  • Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook